Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | NPC1 | O15118 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | RAB9A | P51151 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | PNMT | P11086 | 1/20 | 0.31 |
| ▸ | MAOA | P21397 | 1/20 | 0.31 |
| ▸ | SRD5A2 | P31213 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2965677 | 0.89 | ALDH1A1 (0.36) | KDM4ENPC1ALDH1A1LMNAMAPT | |
| SCHEMBL313500 | 0.80 | PNMT (0.44) | KDM4ENPC1ALDH1A1LMNAMAPT | |
| SCHEMBL1029595 | 0.77 | KDM4E (0.34) | KDM4ENPC1ALDH1A1LMNAMAPT | |
| SCHEMBL217877 | 0.76 | ALDH1A1 (0.36) | KDM4ENPC1ALDH1A1LMNAMAPT | |
| SCHEMBL2974521 | 0.76 | KDM4E (0.36) | KDM4ENPC1ALDH1A1LMNAMAPT | |
| SCHEMBL2964850 | 0.76 | CYP1A2 (0.34) | KDM4ENPC1ALDH1A1LMNAMAPT | |
| SCHEMBL2959178 | 0.76 | PNMT (0.37) | KDM4ENPC1ALDH1A1LMNAMAPT | |
| SCHEMBL2971770 | 0.76 | KDM4E (0.33) | KDM4ENPC1ALDH1A1LMNAMAPT | |
| SCHEMBL216860 | 0.76 | ALDH1A1 (0.38) | KDM4ENPC1ALDH1A1LMNAMAPT | |
| SCHEMBL2478927 | 0.75 | RAB9A (0.40) | KDM4ENPC1ALDH1A1LMNAMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7763562-B2 | Heteroatom bridged metallocene compounds for olefin polymerization | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2010-07-27 | — | — | US | disclosed |
| US-20070135597-A1 | Heteroatom bridged metallocene compounds for olefin polymerization | EXXONMOBIL CHEMICAL PATENTS INC. | 2007-06-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070135597-A1 | Heteroatom bridged metallocene compounds for olefin polymerization | AP2M1, AP1M1, PYM1 | KDM4E 2177/4885NPC1 4083/4885ALDH1A1 4332/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.